Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 677Neoplasms 593Colorectal Neoplasms 292Carcinoma, Non-Small-Cell Lung 292Prostatic Neoplasms 281Lung Neoplasms 223Melanoma 161Multiple Myeloma 150Neoplasm Metastasis 146Head and Neck Neoplasms 143Pancreatic Neoplasms 141Ovarian Neoplasms 133Carcinoma, Hepatocellular 126Leukemia, Myeloid, Acute 123Colonic Neoplasms 112Brain Neoplasms 112Squamous Cell Carcinoma of Head and Neck 111Uterine Cervical Neoplasms 108Stomach Neoplasms 105Recurrence 101Lymphoma 101Glioblastoma 94Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Lymphoma, Non-Hodgkin 82Hematologic Neoplasms 80Urinary Bladder Neoplasms 78Lymphoma, Follicular 78Glioma 75Parkinson Disease 4, Autosomal Dominant Lewy Body 74Leukemia, Lymphocytic, Chronic, B-Cell 72

Interventions

ravulizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Optic Neuritis × 1 year × Clear all
NCT04201262 2025-10-14

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

Alexion Pharmaceuticals, Inc.

Phase 3 Completed
58 enrolled 19 charts

Demyelinating Diseases, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Recurrence

NCT06390579 2025-09-08

BRAIN

Fondation Ophtalmologique Adolphe de Rothschild

Completed
693 enrolled
CNS

Brain Neoplasms, Optic Atrophy, Optic Nerve Diseases, Optic Neuritis, Papilledema, Optic Neuropathy, Ischemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡